Loading…

Evaluation of a Common Receptor-Complement Concept for Predicting the Antileukemic Activity of Nucleosides

The triangulation arrangement of one nitrogen and two oxygen atoms proposed as a requirement for antileukemic activity involving a ``common receptor-complement feature'' has been reevaluated specifically as it applies to nucleosides. This re-evaluation has resulted in a rejection of the ``...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 1979-08, Vol.76 (8), p.4075-4078
Main Authors: Townsend, Leroy B., Schram, Karl H., Beránek, Jirí
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 4078
container_issue 8
container_start_page 4075
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 76
creator Townsend, Leroy B.
Schram, Karl H.
Beránek, Jirí
description The triangulation arrangement of one nitrogen and two oxygen atoms proposed as a requirement for antileukemic activity involving a ``common receptor-complement feature'' has been reevaluated specifically as it applies to nucleosides. This re-evaluation has resulted in a rejection of the ``receptor-complement feature'' as a working model for the a priori design of nucleosides as compounds active against leukemia L-1210.
doi_str_mv 10.1073/pnas.76.8.4075
format article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_383980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>69771</jstor_id><sourcerecordid>69771</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3255-4d9abc455e913e966516d8763f67911ea5b37bf5fd8a8a6a37f9059ab09c6a403</originalsourceid><addsrcrecordid>eNp9kctv1DAQxi3EaylcOSCQcuotwY5f8YHDalUeUlVQVc6W15m0Xpw4xM6K_vc42mVVLj15PN_3mxnpQ-gtwRXBkn4cBxMrKaqmYljyJ2hFsCKlYAo_RSuMa1k2rGYv0asYdxhjxRv8Aj2vFcGCrtDuYm_8bJILQxG6whSb0Pe5vgYLYwpTmf-jhx6GlKVhaRZdmIofE7TOJjfcFukOivWQnIf5F_TOFuvc37t0vwy8mq2HEF0L8TV61hkf4c3xPUM_P1_cbL6Wl9-_fNusL0tLa85L1iqztYxzUISCEoIT0TZS0E5IRQgYvqVy2_GubUxjhKGyU5hnBisrDMP0DH06zB3nbQ-tzadPxutxcr2Z7nUwTv-vDO5O34a9pg1VzcKfH_kp_J4hJt27aMF7M0CYo5ZM1pgxmo3VwWinEOME3WkHwXrJRi_ZaCl0o5dsMvD-4WUn-yGMLH84ygv2T3yInz-m6272PsGflI3vDsZdzBGenEJJSehfqHytlg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74720443</pqid></control><display><type>article</type><title>Evaluation of a Common Receptor-Complement Concept for Predicting the Antileukemic Activity of Nucleosides</title><source>Open Access: PubMed Central</source><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>Townsend, Leroy B. ; Schram, Karl H. ; Beránek, Jirí</creator><creatorcontrib>Townsend, Leroy B. ; Schram, Karl H. ; Beránek, Jirí</creatorcontrib><description>The triangulation arrangement of one nitrogen and two oxygen atoms proposed as a requirement for antileukemic activity involving a ``common receptor-complement feature'' has been reevaluated specifically as it applies to nucleosides. This re-evaluation has resulted in a rejection of the ``receptor-complement feature'' as a working model for the a priori design of nucleosides as compounds active against leukemia L-1210.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.76.8.4075</identifier><identifier>PMID: 291063</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>Animals ; Atoms ; Biochemistry ; Hydroxyls ; Leukemia ; Leukemia L1210 - drug therapy ; Mice ; Molecular Conformation ; Nitrogen ; Nucleosides ; Nucleosides - metabolism ; Nucleosides - therapeutic use ; Oxygen ; Purines ; Receptors, Drug - metabolism ; Structure-Activity Relationship ; Sugars ; Triangulation</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1979-08, Vol.76 (8), p.4075-4078</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/76/8.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/69771$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/69771$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/291063$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Townsend, Leroy B.</creatorcontrib><creatorcontrib>Schram, Karl H.</creatorcontrib><creatorcontrib>Beránek, Jirí</creatorcontrib><title>Evaluation of a Common Receptor-Complement Concept for Predicting the Antileukemic Activity of Nucleosides</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>The triangulation arrangement of one nitrogen and two oxygen atoms proposed as a requirement for antileukemic activity involving a ``common receptor-complement feature'' has been reevaluated specifically as it applies to nucleosides. This re-evaluation has resulted in a rejection of the ``receptor-complement feature'' as a working model for the a priori design of nucleosides as compounds active against leukemia L-1210.</description><subject>Animals</subject><subject>Atoms</subject><subject>Biochemistry</subject><subject>Hydroxyls</subject><subject>Leukemia</subject><subject>Leukemia L1210 - drug therapy</subject><subject>Mice</subject><subject>Molecular Conformation</subject><subject>Nitrogen</subject><subject>Nucleosides</subject><subject>Nucleosides - metabolism</subject><subject>Nucleosides - therapeutic use</subject><subject>Oxygen</subject><subject>Purines</subject><subject>Receptors, Drug - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>Sugars</subject><subject>Triangulation</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><recordid>eNp9kctv1DAQxi3EaylcOSCQcuotwY5f8YHDalUeUlVQVc6W15m0Xpw4xM6K_vc42mVVLj15PN_3mxnpQ-gtwRXBkn4cBxMrKaqmYljyJ2hFsCKlYAo_RSuMa1k2rGYv0asYdxhjxRv8Aj2vFcGCrtDuYm_8bJILQxG6whSb0Pe5vgYLYwpTmf-jhx6GlKVhaRZdmIofE7TOJjfcFukOivWQnIf5F_TOFuvc37t0vwy8mq2HEF0L8TV61hkf4c3xPUM_P1_cbL6Wl9-_fNusL0tLa85L1iqztYxzUISCEoIT0TZS0E5IRQgYvqVy2_GubUxjhKGyU5hnBisrDMP0DH06zB3nbQ-tzadPxutxcr2Z7nUwTv-vDO5O34a9pg1VzcKfH_kp_J4hJt27aMF7M0CYo5ZM1pgxmo3VwWinEOME3WkHwXrJRi_ZaCl0o5dsMvD-4WUn-yGMLH84ygv2T3yInz-m6272PsGflI3vDsZdzBGenEJJSehfqHytlg</recordid><startdate>19790801</startdate><enddate>19790801</enddate><creator>Townsend, Leroy B.</creator><creator>Schram, Karl H.</creator><creator>Beránek, Jirí</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19790801</creationdate><title>Evaluation of a Common Receptor-Complement Concept for Predicting the Antileukemic Activity of Nucleosides</title><author>Townsend, Leroy B. ; Schram, Karl H. ; Beránek, Jirí</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3255-4d9abc455e913e966516d8763f67911ea5b37bf5fd8a8a6a37f9059ab09c6a403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Animals</topic><topic>Atoms</topic><topic>Biochemistry</topic><topic>Hydroxyls</topic><topic>Leukemia</topic><topic>Leukemia L1210 - drug therapy</topic><topic>Mice</topic><topic>Molecular Conformation</topic><topic>Nitrogen</topic><topic>Nucleosides</topic><topic>Nucleosides - metabolism</topic><topic>Nucleosides - therapeutic use</topic><topic>Oxygen</topic><topic>Purines</topic><topic>Receptors, Drug - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>Sugars</topic><topic>Triangulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Townsend, Leroy B.</creatorcontrib><creatorcontrib>Schram, Karl H.</creatorcontrib><creatorcontrib>Beránek, Jirí</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Townsend, Leroy B.</au><au>Schram, Karl H.</au><au>Beránek, Jirí</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of a Common Receptor-Complement Concept for Predicting the Antileukemic Activity of Nucleosides</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1979-08-01</date><risdate>1979</risdate><volume>76</volume><issue>8</issue><spage>4075</spage><epage>4078</epage><pages>4075-4078</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>The triangulation arrangement of one nitrogen and two oxygen atoms proposed as a requirement for antileukemic activity involving a ``common receptor-complement feature'' has been reevaluated specifically as it applies to nucleosides. This re-evaluation has resulted in a rejection of the ``receptor-complement feature'' as a working model for the a priori design of nucleosides as compounds active against leukemia L-1210.</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>291063</pmid><doi>10.1073/pnas.76.8.4075</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1979-08, Vol.76 (8), p.4075-4078
issn 0027-8424
1091-6490
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_383980
source Open Access: PubMed Central; JSTOR Archival Journals and Primary Sources Collection
subjects Animals
Atoms
Biochemistry
Hydroxyls
Leukemia
Leukemia L1210 - drug therapy
Mice
Molecular Conformation
Nitrogen
Nucleosides
Nucleosides - metabolism
Nucleosides - therapeutic use
Oxygen
Purines
Receptors, Drug - metabolism
Structure-Activity Relationship
Sugars
Triangulation
title Evaluation of a Common Receptor-Complement Concept for Predicting the Antileukemic Activity of Nucleosides
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A17%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20a%20Common%20Receptor-Complement%20Concept%20for%20Predicting%20the%20Antileukemic%20Activity%20of%20Nucleosides&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Townsend,%20Leroy%20B.&rft.date=1979-08-01&rft.volume=76&rft.issue=8&rft.spage=4075&rft.epage=4078&rft.pages=4075-4078&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.76.8.4075&rft_dat=%3Cjstor_pubme%3E69771%3C/jstor_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3255-4d9abc455e913e966516d8763f67911ea5b37bf5fd8a8a6a37f9059ab09c6a403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=74720443&rft_id=info:pmid/291063&rft_jstor_id=69771&rfr_iscdi=true